Juliette Cubanski, PhD
Articles
July 15th 2021
Trends in Medicare Part D Coverage of Generics With Equivalent Brand-Name Drugs
Stacie B. Dusetzina, PhD Juliette Cubanski, PhD Andrew W. Roberts, PharmD, PhD Jack Hoadley, PhD Sarah True, MPH, MSW Leonce Nshuti, MSc Tricia Neuman, ScD
High-tier generic drug placement in Medicare Part D has increased over time, but it may be related to a drug’s clinical profile and availability of substitutes rather than preferred brand-name drug coverage.
Latest Updated Articles
Published: May 9th 2024 | Updated: May 21st 2024
FDA Accepts Nivolumab Subcutaneous Injection Application, With Potential to Boost Access to PD-1 Inhibitors
Published: August 6th 2024 | Updated: September 17th 2024
Rising Costs Lead Insurers to Drop Weight Loss Drug Coverage, Further Increasing Patient Burden
Published: August 16th 2024 | Updated: September 17th 2024
How Can We Improve Obesity Care in 2024 and Beyond?
Published: September 12th 2024 | Updated: September 17th 2024
The American Journal of Managed Care® Announces Lisa Rotenstein, M.D., MBA, as the Recipient of the Seema S. Sonnad Emerging Leader in Managed Care Research Award
Published: April 23rd 2024 | Updated: September 17th 2024
The American Journal of Managed Care® Announces Call for Manuscript Submissions for the 14th Annual Health Information Technology Special Issue
Published: September 10th 2024 | Updated: September 17th 2024
Different Options for Different People: Dr Bellinda King-Kallimanis Explores the State of Patient Education in Lung Cancer
